Koppikar Utpal 4
4 · Atara Biotherapeutics, Inc. · Filed Jun 10, 2022
Insider Transaction Report
Form 4
Koppikar Utpal
Chief Financial Officer
Transactions
- Sale
Common Stock
2022-06-08$5.63/sh−5,853$32,952→ 203,529 total
Footnotes (2)
- [F1]Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units.
- [F2]Includes 1,790 shares purchased under the Issuer's Employee Stock Purchase Plan on May 31, 2022.